Literature DB >> 7729458

Lack of effect of orally administered human serum immunoglobulin on the normal human oral and intestinal microflora.

A K Bogstedt1, C E Nord, L Hammarström.   

Abstract

The aim of this study was to investigate the influence of large doses of orally administered human IgG on the normal gastrointestinal microflora of healthy volunteers since human immunoglobulin has been tried as oral prophylaxis and therapy in gastrointestinal infections. Ten adult healthy volunteers received 10 g of IgG orally, once daily for three consecutive days. Aerobic and anaerobic microorganisms were identified in the saliva and stool specimens, using morphological, biochemical and serological tests and gas-liquid chromatography. Although the immunoglobulin preparation contains antibodies against a variety of microorganisms, there were no significant changes in the numbers of different aerobic and anaerobic microorganisms due to the oral intake of the immunoglobulin. IgG may, therefore, be used against pathogens without disturbing the normal oral and intestinal microflora.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729458     DOI: 10.1007/bf02112623

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Treatment of chronic cryptosporidial infection with orally administered human serum immune globulin.

Authors:  S M Borowitz; F T Saulsbury
Journal:  J Pediatr       Date:  1991-10       Impact factor: 4.406

2.  Benefit of oral immune globulin therapy in patients with immunodeficiency and chronic diarrhea.

Authors:  I Melamed; A M Griffiths; C M Roifman
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

3.  Enteral immunoglobulins for treatment of protracted rotaviral diarrhea.

Authors:  A Guarino; S Guandalini; F Albano; A Mascia; G De Ritis; A Rubino
Journal:  Pediatr Infect Dis J       Date:  1991-08       Impact factor: 2.129

4.  Oral immunoglobulin treatment in Campylobacter jejuni enteritis.

Authors:  V Hammarström; C I Smith; L Hammarström
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

5.  Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man.

Authors:  A Heimdahl; C E Nord
Journal:  Scand J Infect Dis       Date:  1979

6.  Nasal administration of immunoglobulin as effective prophylaxis against infections in elite cross-country skiers.

Authors:  P Hemmingsson; L Hammarström
Journal:  Scand J Infect Dis       Date:  1993

7.  A randomised trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus.

Authors:  G L Barnes; L W Doyle; P H Hewson; A M Knoches; J A McLellan; W H Kitchen; R F Bishop
Journal:  Lancet       Date:  1982-06-19       Impact factor: 79.321

8.  Survival of oral human immune serum globulin in the gastrointestinal tract of low birth weight infants.

Authors:  P M Blum; D L Phelps; B J Ank; H J Krantman; E R Stiehm
Journal:  Pediatr Res       Date:  1981-09       Impact factor: 3.756

Review 9.  Protective factors in milk and the development of the immune system.

Authors:  L A Hanson; S Ahlstedt; B Andersson; B Carlsson; S P Fällström; L Mellander; O Porras; T Söderström; C S Edén
Journal:  Pediatrics       Date:  1985-01       Impact factor: 7.124

Review 10.  Prophylaxis of necrotizing enterocolitis by oral IgA-IgG: review of a clinical study in low birth weight infants and discussion of the pathogenic role of infection.

Authors:  M M Eibl; H M Wolf; H Fürnkranz; A Rosenkranz
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

View more
  1 in total

1.  A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.

Authors:  Benjamin L Handen; Raun D Melmed; Robin L Hansen; Michael G Aman; David L Burnham; Jon B Bruss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-01-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.